Clinical Trials Logo

Clinical Trial Summary

National clinical trial, phase III, multicenter, randomized, prospective, double-blind, parallel, placebo-controlled, which one hundred and fifty (150) subjects of both sexes aged equal or more than 18 years will be randomly allocated to one the drug group or placebo group.


Clinical Trial Description

The investigational product is a combination of desloratadine, phenylephrine hydrochloride and ibuprofen.

The desloratadine is a antihistamine and selectively block the activity of histamine receptor-1 (H1) resulting in a non sedative and prolong antiallergic effect.

The phenylephrine is a potent stimulator of the postsynaptic α receptor with minimal effect on β receptors in the heart.

The ibuprofen's mechanism is not fully known. It is a non selective inhibitor of cyclooxygenase, an enzyme that is involved in prostaglandin synthesis by the route from arachidonic acid. It is believed that the pharmacological effects are due to inhibition of cyclooxygenase-2 (COX-2), which reduces prostaglandin synthesis involved in the mediation of inflammation, pain, fever and swelling. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02904304
Study type Interventional
Source Ache Laboratorios Farmaceuticos S.A.
Contact
Status Suspended
Phase Phase 3
Start date December 2020
Completion date September 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02735070 - Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold Phase 3
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Not yet recruiting NCT05118672 - Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment Phase 3
Recruiting NCT06158659 - Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula N/A
Active, not recruiting NCT05190432 - Taxifolin/Ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) N/A
Not yet recruiting NCT03089138 - Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome Phase 2
Completed NCT00289237 - Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease N/A
Recruiting NCT05728918 - Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People N/A
Recruiting NCT02183779 - PORH and Response to Cold in Raynaud's Phenomenon. N/A
Completed NCT05920915 - The Effect of the Cold Application on Venous Cannulation Pain N/A
Recruiting NCT05454826 - Investigation of the Effect of Cold Application in Migraine N/A
Recruiting NCT04277494 - The Acute Effect of Cold Spray Application on the Mechanical Properties of the Quadriceps Muscle in Athletes N/A
Completed NCT01533220 - Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal Phase 3
Not yet recruiting NCT04277481 - The Acute Effect of Cold Pack Therapy Applied on Healthy People for Different Periods
Completed NCT03769012 - Ability of Beta-glucan Supplementation to Augment Immune Function N/A
Completed NCT02238210 - Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy Phase 4
Recruiting NCT05435144 - Elderberry for Immune Support N/A
Completed NCT02847663 - The Effect of Whole Body Cryotherapy on Recovery and Performance: a Randomized Controlled Trial N/A
Recruiting NCT02457533 - Case Management - Active Telephone Support to Patients With COLD N/A
Not yet recruiting NCT05317156 - The Effect of Cold Vapor on Intubation-Related Symptoms and Comfort in the Early Postoperative Period N/A